Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Philip Brooks’ Patent Infringement UpdatesGoodenough Ex Parte Reexamination Certificate Issued
By Philip Brooks
Today, May 12, 2009, US 6,514,640 C1 issued under 35 U.S.C. 307 with the following findings:
As a result of reexamination, it has been determined that:
Claim 25 is cancelled.
Claims 1, 2, 17 and 24 are determined to be patentable as amended.
Claims 3-6, 10-16 and 18-23, dependent on an amended claim, are determined to be patentable.
Claims 7-9 were not reexamined.
Download US 6,514,640 C1 reexamination certificate.
Full post as published by Philip Brooks’ Patent Infringement Updates on May 12, 2009 (boomark / email).
Nationwide Recall Issued for Certain Lots of Cleviprex
Nationwide Recall Issued for Certain Lots of Cleviprex
Class 1 Recall Issued for Penumbra Neuron 5F Select Catheter
Class 1 Recall Issued for Penumbra Neuron 5F Select Catheter>
Nationwide Recall Issued for Specific Lots of Atlas "Dietary Supplements"
Nationwide Recall Issued for Specific Lots of Atlas "Dietary Supplements"
Brave Log Splitters
New Recalls Issued
Zencore Plus
Nationwide Recall Issued
DYMO LabelWriter Power Adapters
Recall issued

Ex Parte Reexamination Statistics II
Second Viread® Patent Survives Reexamination
Ex Parte Reexamination Statistics
Latest Ex Parte Reexamination Statistics from the PTO
Pfizer's Lipitor '893 Patent Survives Reexamination
USPTO: Reexaminations May Not Be "Specially Expedited"







